GlassScriptPhysician profile
Ricardo Requena
NPI 1093751000
$2,300.60
in general payments reported to CMS, 2019-2025
22 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $177 · 2021: $195 · 2022: $421 · 2023: $369 · 2024: $552 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.32 |
| Education | $133.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $475.89 | 2023-2025 | Dupixent |
| Optinose US, INC. | $366.60 | 2019-2025 | |
| Alk-Abello, INC | $263.77 | 2019-2023 | Ragwitek, Odactra, Grastek |
| Glaxosmithkline, LLC. | $193.24 | 2019-2025 | Nucala, Trelegy Ellipta |
| Stryker Corporation | $176.85 | 2020-2022 | |
| Neurent Medical Limited | $165.78 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Genzyme Corporation | $112.36 | 2021-2025 | |
| C2dx, INC | $81.14 | 2023 | |
| Medtronic USA, INC. | $73.24 | 2020 | |
| Lucid Diagnostics INC. | $55.58 | 2022-2023 | |
| Kaleo, INC. | $49.17 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $44.66 | 2019-2022 | |
| Acclarent, INC | $43.97 | 2022 | |
| Organogenesis INC. | $38.09 | 2025 | Cygnus Dual |
| Integra Lifesciences Corporation | $30.48 | 2023-2024 | Instruments-Orthopedic, Integra Duo, Integra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $24.04 | 2024 | Immunocap |
| Merck Sharp & Dohme LLC | $22.98 | 2023 | |
| Medtronic, INC. | $20.90 | 2025 | Propel |
| Hologic Sales and Service, LLC | $16.60 | 2022 | |
| Acera Surgical, INC. | $16.59 | 2020 | |
| Smith+Nephew, INC. | $15.52 | 2019 | |
| Aerin Medical INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Requena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.